. february 2012 (21)..eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. https://oakley-sunglassesformen.us/Vecino-brother-of-Mumme-from-Montreal?Cheanson=142 .....movie times